nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alectinib relieves ischemic strokes caused by left atrial metastasis in a NSCLC patient with a novel SLC34A2-ALK (exon 1: exon 15) fusion
|
Zhou, Na |
|
|
183 |
C |
p. |
artikel |
2 |
A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations
|
Saltos, Andreas N. |
|
|
183 |
C |
p. |
artikel |
3 |
Bronchial carcinoid tumors in children and adolescents – A report and management considerations from the German MET studies
|
Abele, Michael |
|
|
183 |
C |
p. |
artikel |
4 |
Comment on: Chemoradiation-induced pneumonitis in patients with unresectable stage III non-small cell lung cancer
|
Zhang, Hangyue |
|
|
183 |
C |
p. |
artikel |
5 |
Contents
|
|
|
|
183 |
C |
p. |
artikel |
6 |
Corrigendum to “Safety of pemetrexed plus platinum in combination with pembrolizumab for metastatic nonsquamous non-small cell lung cancer: A post hoc analysis of KEYNOTE-189” [Lung Cancer 155 (2021) 53–60]
|
Garon, Edward B. |
|
|
183 |
C |
p. |
artikel |
7 |
Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective study
|
Chen, Jiayan |
|
|
183 |
C |
p. |
artikel |
8 |
Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC
|
Cucchiara, Federico |
|
|
183 |
C |
p. |
artikel |
9 |
Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer
|
Conroy, Michael R. |
|
|
183 |
C |
p. |
artikel |
10 |
Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes
|
Blanco, Remei |
|
|
183 |
C |
p. |
artikel |
11 |
Safety and efficacy of atezolizumab in Chinese patients with previously treated locally advanced or metastatic non-small cell lung cancer: An open-label, single-arm, multicenter study
|
Xu, Yanjun |
|
|
183 |
C |
p. |
artikel |
12 |
“The challenge is the complexity” – A qualitative study about decision-making in advanced lung cancer treatment
|
Orstad, Silje |
|
|
183 |
C |
p. |
artikel |